Form 4: CCRN CHRO Receives Restricted Stock Post-Merger Termination

Cross Country Healthcare's Chief Human Resources Officer, Colin McDonald, was granted 9,340 restricted shares following the termination of a merger agreement.

Summary

• Colin Patrick McDonald, Chief Human Resources Officer of Cross Country Healthcare, Inc. (CCRN), acquired 9,340 shares of common stock.
• The shares are Restricted Stock Awards (RSAs) granted on December 18, 2025, with a price of $0 per share.
• These RSAs will vest in three substantially equal installments on December 18, 2026, March 31, 2027, and March 31, 2028.
• The Compensation Committee approved the grant on December 18, 2025, instead of March 31, 2025, due to the termination of a Merger Agreement.
• The Merger Agreement was with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc., and was terminated on December 3, 2025.
• The adjusted vesting schedule aligns with previously granted RSAs of the company.

Sentiment

Score: 6

Explanation: The grant of restricted stock to a key executive is generally a positive event for the executive and can be viewed as a positive for aligning management incentives with shareholder interests. While the underlying reason (merger termination) could be negative, the compensation action itself is a standard practice.

Positives

• The grant of 9,340 restricted shares to the Chief Human Resources Officer aligns executive incentives with shareholder interests.
• The adjusted vesting schedule ensures consistency with the company's existing RSA programs.

Negatives

• No direct negatives are reported within this specific Form 4 filing regarding the stock grant itself.

Risks

• The termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025, could imply strategic or operational risks for the company, though this filing does not detail them.

Future Outlook

The restricted shares granted to the Chief Human Resources Officer are scheduled to vest in three installments over the next three years, concluding by March 31, 2028, aligning with the company's existing vesting schedules for similar awards.

Industry Context

The grant of restricted stock to a key executive, particularly following the termination of a significant merger agreement, indicates the company's focus on retaining talent and realigning executive incentives amidst strategic shifts in the healthcare staffing industry. The terminated merger with Aya Healthcare, Inc. suggests a change in the company's growth strategy or market positioning.

Comparison to Industry Standards

• NA This filing primarily details an individual executive's compensation event. A comprehensive comparison would require detailed data on executive compensation packages (including base salary, bonuses, and equity awards) for Chief Human Resources Officers at comparable companies within the healthcare staffing sector, which is not provided in this Form 4.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of restricted shares represents a minor dilution of existing shares but aims to align the interests of a key executive with long-term shareholder value.
• Employees: The compensation decision for a senior executive may influence overall employee morale and perception of compensation practices within the company.
• Executive (Colin Patrick McDonald): Receives a significant equity award, enhancing personal wealth and long-term incentive to contribute to company performance.

Next Steps

• The restricted shares will vest in three installments on December 18, 2026, March 31, 2027, and March 31, 2028.

Key Dates

Keywords

Cross Country Healthcare, CCRN, Restricted Stock Award, RSA, Insider Transaction, Executive Compensation, Merger Termination, Colin McDonald, Form 4